{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3627, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-f69d-70fd-b7d0-6f51252ace8d", "docSlug": "3a2bf5c694d790cfc044cbae9240c840", "documentTitle": "Flutter | Investor Presentation Deck | 28 slides", "authorId": "flutter", "authorName": "Flutter Entertainment", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Includes a map of Turkey, a bar chart comparing gaming spend as % of GDP, and two bar charts showing growth in turnover and online stake penetration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f69d-70fd-b7d0-6f51252ace8d/24", "deckHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d", "deckAnchorHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 9, "beatId": "84fd249f-2f02-4745-8f8c-aaaca26fe1b8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-28 present the solution, including case studies and financial performance", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f69d-70fd-b7d0-6f51252ace8d", "docSlug": "3a2bf5c694d790cfc044cbae9240c840", "documentTitle": "Flutter | Investor Presentation Deck | 28 slides", "authorId": "flutter", "authorName": "Flutter Entertainment", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes Sustainalytics ranking as a validation metric.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f69d-70fd-b7d0-6f51252ace8d/25", "deckHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d", "deckAnchorHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 9, "beatId": "84fd249f-2f02-4745-8f8c-aaaca26fe1b8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-28 present the solution, including case studies and financial performance", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f69d-70fd-b7d0-6f51252ace8d", "docSlug": "3a2bf5c694d790cfc044cbae9240c840", "documentTitle": "Flutter | Investor Presentation Deck | 28 slides", "authorId": "flutter", "authorName": "Flutter Entertainment", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f69d-70fd-b7d0-6f51252ace8d/26", "deckHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d", "deckAnchorHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 9, "beatId": "84fd249f-2f02-4745-8f8c-aaaca26fe1b8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-28 present the solution, including case studies and financial performance", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f69d-70fd-b7d0-6f51252ace8d", "docSlug": "3a2bf5c694d790cfc044cbae9240c840", "documentTitle": "Flutter | Investor Presentation Deck | 28 slides", "authorId": "flutter", "authorName": "Flutter Entertainment", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f69d-70fd-b7d0-6f51252ace8d/27", "deckHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d", "deckAnchorHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 9, "beatId": "84fd249f-2f02-4745-8f8c-aaaca26fe1b8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-28 present the solution, including case studies and financial performance", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f69d-70fd-b7d0-6f51252ace8d", "docSlug": "3a2bf5c694d790cfc044cbae9240c840", "documentTitle": "Flutter | Investor Presentation Deck | 28 slides", "authorId": "flutter", "authorName": "Flutter Entertainment", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f69d-70fd-b7d0-6f51252ace8d/28", "deckHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d", "deckAnchorHref": "/decks/019de075-f69d-70fd-b7d0-6f51252ace8d#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 28, "from": 9, "beatId": "84fd249f-2f02-4745-8f8c-aaaca26fe1b8", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-28 present the solution, including case studies and financial performance", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo, tagline, and date.", "imagePath": "https://imgproxy.kitesheet.com/hd5S-xAiXrjmRNGWfv5TJn9C5dw-OKI1GuKf9ugGBs8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNTJlZTQxNmU2YTk3YTliMzllMTMwOWZhZmRhYjBmMy9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/1", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "e444b487-fcb2-4bdd-9b87-8dd886121483", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The initial slides introduce the problem and highlight the limitations of current oncolytic immunotherapies.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/DTVfwdEfBkZC45tvrz_r12FlpDpUyomE-8INAVPruWM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNTJlZTQxNmU2YTk3YTliMzllMTMwOWZhZmRhYjBmMy9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/HiCFMiUJaPcB2MEv3-tMliW5f36P25z1E8WYb3ZxJX4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNTJlZTQxNmU2YTk3YTliMzllMTMwOWZhZmRhYjBmMy9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/O9Fz_ziPydBMi3ToiAMbGsvbUvL8XNhk3d0A3VyK3E4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zNTJlZTQxNmU2YTk3YTliMzllMTMwOWZhZmRhYjBmMy9wMDAxLnBuZw" }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/2", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "e444b487-fcb2-4bdd-9b87-8dd886121483", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The initial slides introduce the problem and highlight the limitations of current oncolytic immunotherapies.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/3", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "e444b487-fcb2-4bdd-9b87-8dd886121483", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The initial slides introduce the problem and highlight the limitations of current oncolytic immunotherapies.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a three-column layout to highlight key value propositions of the Olvi-Vec technology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/4", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-4", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "38515402-0f9a-4e9b-81f7-00348eb645d5", "evidence": "The deck highlights the limitations and challenges of current treatments, implicitly raising the question of what if we don't innovate.", "position": 0, "objective": "What if we don't adopt a new approach to oncolytic immunotherapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 4, "beatId": "fdbee508-b41b-482b-8db8-5d1f0a14e7b6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 4-9 emphasize the complications and challenges of current treatments, including resistance and refractoriness.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to show clinical trial stages for multiple drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/5", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-5", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "38515402-0f9a-4e9b-81f7-00348eb645d5", "evidence": "The deck highlights the limitations and challenges of current treatments, implicitly raising the question of what if we don't innovate.", "position": 0, "objective": "What if we don't adopt a new approach to oncolytic immunotherapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 4, "beatId": "fdbee508-b41b-482b-8db8-5d1f0a14e7b6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 4-9 emphasize the complications and challenges of current treatments, including resistance and refractoriness.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "Uses a process diagram to illustrate the transition from cold to hot tumor states via viral infection.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/6", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-6", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "38515402-0f9a-4e9b-81f7-00348eb645d5", "evidence": "The deck highlights the limitations and challenges of current treatments, implicitly raising the question of what if we don't innovate.", "position": 0, "objective": "What if we don't adopt a new approach to oncolytic immunotherapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 4, "beatId": "fdbee508-b41b-482b-8db8-5d1f0a14e7b6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 4-9 emphasize the complications and challenges of current treatments, including resistance and refractoriness.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "The central diagram shows a biological mechanism comparing 'Absence of Effector T Cells' (Platinum resistant) vs 'Presence of Effector T Cells' (Platinum sensitive).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/7", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-7", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "38515402-0f9a-4e9b-81f7-00348eb645d5", "evidence": "The deck highlights the limitations and challenges of current treatments, implicitly raising the question of what if we don't innovate.", "position": 0, "objective": "What if we don't adopt a new approach to oncolytic immunotherapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 4, "beatId": "fdbee508-b41b-482b-8db8-5d1f0a14e7b6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 4-9 emphasize the complications and challenges of current treatments, including resistance and refractoriness.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a timeline to establish market maturity and investor confidence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/8", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-8", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "38515402-0f9a-4e9b-81f7-00348eb645d5", "evidence": "The deck highlights the limitations and challenges of current treatments, implicitly raising the question of what if we don't innovate.", "position": 0, "objective": "What if we don't adopt a new approach to oncolytic immunotherapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 4, "beatId": "fdbee508-b41b-482b-8db8-5d1f0a14e7b6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 4-9 emphasize the complications and challenges of current treatments, including resistance and refractoriness.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a list-based comparison and a logo-grid to frame the competitive landscape.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/9", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-9", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "38515402-0f9a-4e9b-81f7-00348eb645d5", "evidence": "The deck highlights the limitations and challenges of current treatments, implicitly raising the question of what if we don't innovate.", "position": 0, "objective": "What if we don't adopt a new approach to oncolytic immunotherapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 4, "beatId": "fdbee508-b41b-482b-8db8-5d1f0a14e7b6", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "Slides 4-9 emphasize the complications and challenges of current treatments, including resistance and refractoriness.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide uses a pyramid diagram to represent the evolution of oncolytic virus technology, with Genelux's platform at the top.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/10", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a document-style callout for key takeaways and a vertical icon-list for clinical data points.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/11", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process-flow layout to show the trial design and its validation through publications and follow-up trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/12", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "Data table presents ORR, Duration of Response, CA-125 response, PFS, and OS across patient subgroups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/13", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Waterfall plot and spider plot showing patient-level clinical outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/14", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a series of bar charts to compare PFS across multiple treatment regimens for three specific patients (15B-01, 15B-15, 15B-17).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/15", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "Kaplan-Meier survival curve showing superior performance of VIRO-15 compared to historical 4th line treatment data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/16", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "key_takeaways", "function": "summarize", "notes": "The chart compares cross-trial data; the footnote explicitly warns against direct comparison due to protocol differences.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/17", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines a clinical trial protocol for Olvi-Vec in ovarian cancer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/18", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_takeaways", "function": "show_traction", "notes": "Includes Kaplan-Meier survival curves and dose escalation scatter plots for two distinct patient groups.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/19", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "Includes specific patient case reports (Pt #21A-06 and Pt #21A-04) as evidence of efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/20", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "Includes a bio for Benny Li, PhD, CEO of Newsoara.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/21", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "The slide highlights a strategic partnership, funding, and commercial rights split between US and Greater China markets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/22", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "solution", "function": "present_solution", "notes": "The slide highlights a combination therapy approach involving oncolytic immunotherapy and adoptive cell therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/23", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a map of the US as a background to anchor the market sizing to a specific geography.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/24", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-24", "loopMatches": [ { "to": 26, "from": 24, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "392920d4-0517-46aa-a9c2-4fb0dd0c15fd", "evidence": "The deck discusses the market opportunity and commercial potential of Olvi-Vec, highlighting its potential to address unmet needs.", "position": 1, "objective": "How can Olvi-Vec address the needs of patients and healthcare systems?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "other", "function": "present_solution", "notes": "The slide highlights physical assets and operational capacity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/25", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-25", "loopMatches": [ { "to": 26, "from": 24, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "392920d4-0517-46aa-a9c2-4fb0dd0c15fd", "evidence": "The deck discusses the market opportunity and commercial potential of Olvi-Vec, highlighting its potential to address unmet needs.", "position": 1, "objective": "How can Olvi-Vec address the needs of patients and healthcare systems?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "go_to_market", "function": "plan_implementation", "notes": "The slide uses a hub-and-spoke style layout to show the four pillars supporting the central launch strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/26", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-26", "loopMatches": [ { "to": 26, "from": 24, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "392920d4-0517-46aa-a9c2-4fb0dd0c15fd", "evidence": "The deck discusses the market opportunity and commercial potential of Olvi-Vec, highlighting its potential to address unmet needs.", "position": 1, "objective": "How can Olvi-Vec address the needs of patients and healthcare systems?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "solution", "function": "present_solution", "notes": "The slide categorizes the platform's capabilities into therapeutic genes, immune modularity, and therapeutic antibodies, emphasizing non-GMO status and GLP tox readiness.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/27", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "unfair_advantage", "function": "present_solution", "notes": "The slide highlights key defensive moats including patent counts, expiration dates, and lack of royalty obligations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/28", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout to categorize team members into three distinct groups: Executive Team, Board of Directors, and Operations & R&D.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/29", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a combination of a checklist for past achievements and a timeline arrow for future goals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/30", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes footnotes regarding market close date and specific financing obligations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/31", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/32", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "appendix", "function": "appendix", "notes": "The slide indicates this is an appendix section of an October 2023 corporate presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/33", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "team_bio", "function": "other", "notes": "The slide lists key advisors, some of whom also hold executive roles (CEO, CMO, CFO) within the company.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/34", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "key_takeaways", "function": "show_traction", "notes": "Includes microscopic imagery of patient samples (Pt.#15A-01 and Pt.#15A-11) showing longitudinal progression of treatment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/35", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "traction", "function": "show_traction", "notes": "The slide compares pre- and post-treatment biopsies for three patients (15A-16, 15A-18, 15A-23) using both visual microscopy and quantitative infiltration histograms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/36", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a combination of a bar chart (ELISPOT data) and a line chart (SLD over time) to show clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/37", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f745-744d-a2c3-62fcecd316e9", "docSlug": "352ee416e6a97a9b39e1309fafdab0f3", "documentTitle": "Genelux | Investor Presentation Deck | 38 slides", "authorId": "genelux", "authorName": "Genelux", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "solution", "function": "present_solution", "notes": "The slide uses clinical study data (VIRO-15, NCT01443260) to support its claims.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f745-744d-a2c3-62fcecd316e9/38", "deckHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9", "deckAnchorHref": "/decks/019de075-f745-744d-a2c3-62fcecd316e9#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 38, "from": 10, "beatId": "523d1cf4-1cd0-4572-8561-e435ff7a2275", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 10-38 present Olvi-Vec as a solution, detailing its competitive advantages, clinical results, and market potential.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes list of geographic locations and KBW branding.", "imagePath": "https://imgproxy.kitesheet.com/8tkk2MSRd4KuPjQjUgYO5g_ICwQ4DNRprYXH2S3ETCk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OTBlMmFhMzExMzY1MWJmYWFiOWNhYmZmNjI5ZjhmNi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/1", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/uGRz-rDdsKNlY5qxhxx60VEu8Go7EAKqiGnSkYw4D2o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OTBlMmFhMzExMzY1MWJmYWFiOWNhYmZmNjI5ZjhmNi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/49BaGFTN-TBOffrSiyafajzWAbHwMTL6bUsThauMxIU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OTBlMmFhMzExMzY1MWJmYWFiOWNhYmZmNjI5ZjhmNi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/bob62q7f2Rx94LEr2UkNNnVwM9fnOMNjaZuXyPxAZQ0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy81OTBlMmFhMzExMzY1MWJmYWFiOWNhYmZmNjI5ZjhmNi9wMDAxLnBuZw" }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/2", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/3", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "table_of_contents", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/4", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "kpi_overview", "function": "summarize", "notes": "Includes a map of US branches and LPOs, and a sidebar of financial KPIs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/5", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "8c41b0a5-a15f-49e5-bd7a-e2afafae83c2", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with an overview of Hanmi's franchise and key takeaways", "position": 0, "confidence": 0.6, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/6", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "8c41b0a5-a15f-49e5-bd7a-e2afafae83c2", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with an overview of Hanmi's franchise and key takeaways", "position": 0, "confidence": 0.6, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "timeline", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/7", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "8c41b0a5-a15f-49e5-bd7a-e2afafae83c2", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with an overview of Hanmi's franchise and key takeaways", "position": 0, "confidence": 0.6, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a 2x2 quadrant layout to organize key performance metrics and strategic highlights.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/8", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 5, "beatId": "8c41b0a5-a15f-49e5-bd7a-e2afafae83c2", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation starts with an overview of Hanmi's franchise and key takeaways", "position": 0, "confidence": 0.6, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/9", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide includes detailed footnotes regarding specific loan categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/10", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/11", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "before_after", "function": "analyze_data", "notes": "Uses a bridge-style donut chart comparison to show portfolio evolution over a decade.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/12", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-12", "loopMatches": [ { "to": 13, "from": 12, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "77f409a9-4a06-4a64-82df-b2fc9171d645", "evidence": "The presentation uses a before-after loop to highlight the success of Hanmi's portfolio diversification strategy", "position": 0, "objective": "Showcasing successful portfolio diversification strategy", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes detailed footnotes explaining loan classifications and calculation methodologies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/13", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-13", "loopMatches": [ { "to": 13, "from": 12, "name": "Before After", "slug": "21-before-after", "bestFor": "Product demos, process improvements, ROI justification", "matchId": "77f409a9-4a06-4a64-82df-b2fc9171d645", "evidence": "The presentation uses a before-after loop to highlight the success of Hanmi's portfolio diversification strategy", "position": 0, "objective": "Showcasing successful portfolio diversification strategy", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "confidence": 0.8, "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison" } ], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses two donut charts to visualize the composition of two distinct loan portfolios.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/14", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses donut charts to visualize the geographical concentration of different CRE loan categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/15", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide presents three distinct tables summarizing financial data for different loan categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/16", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-f818-73eb-a066-c7c79e80120d", "docSlug": "590e2aa3113651bfaab9cabff629f8f6", "documentTitle": "Hanmi Financial | Results Presentation Deck | 48 slides", "authorId": "hanmi-financial", "authorName": "Hanmi Financial", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table includes a footnote regarding C&I lines of credit and rounding.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-f818-73eb-a066-c7c79e80120d/17", "deckHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d", "deckAnchorHref": "/decks/019de075-f818-73eb-a066-c7c79e80120d#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 9, "beatId": "90eff337-241f-473d-b563-50f43bf9c547", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation showcases Hanmi's diversified loan portfolio and strong financial performance", "position": 1, "confidence": 0.6, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }